No Picture
News

Karyopharm taps longtime Pfizer, Amgen vet to steer the ship; With Merck in the rearview mirror, Roger Perlmutter stakes his claim to a CEO job — and it’s a surprising choice

Richard Paulson Like many who work in biopharma, Richard Paulson got started in the field because of a love of science. Paulson had just finished business school and was looking to start a career that married his two passions. While looking for jobs, h… […]

No Picture
News

Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future

LOS ANGELES & NEW YORK–(BUSINESS WIRE)– #IPOs–Science 37, Inc. and LifeSci Acquisition II Corp announced that they have entered into a definitive business combination agreement. […]

No Picture
News

Jasper and its stem cell conditioning antibody earn a ticket to Nasdaq in latest SPAC reverse merger

Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here. Another biotech SPAC deal has landed as the glut of blank-check companies continues to make waves in the industry. Thursday’s winner is Jas… […]